Abstract
Our study evaluates the performance of two rapid phenotypical tests to detect colistin resistance in Enterobacterales: Alifax rapid AST colistin test using the HB&L system and Rapid Polymyxin NP test prepared in-house. A collection of well-characterized 53 colistin-susceptible and 66 colistin-resistantEnterobacterales isolates was used. The results obtained using both rapid tests were compared to the reference broth microdilution. Overall categorical agreement was 81.5% for Alifax test and 98.3% for Rapid Polymyxin NP test. Based on our results, the Rapid Polymyxin NP test is superior to the Alifax test that performed inadequate for Enterobacter spp.
Highlights
Colistin use in clinical practice is mainly restricted to treatment of severe infections caused by multidrug-resistant (MDR) Gram-negative bacilli (GNB) [1]
This study evaluates the performance of two rapid tests that detect colistin resistance in Enterobacterales isolates and compares the results with the reference broth microdilution (BMD)
Among the 66 colistin-resistant isolates, categorical agreement (CA) determined per species/ genus was 100.0% for E. coli, 100.0% for K. pneumoniae, 88.9% for Enterobacter spp., and 100.0% for Citrobacter spp
Summary
Colistin use in clinical practice is mainly restricted to treatment of severe infections caused by multidrug-resistant (MDR) Gram-negative bacilli (GNB) [1]. It is rarely included in routine susceptibility panels in medical microbiology laboratories. Colistin susceptibility testing is methodologically challenging due to its inherent properties [1,2,3]. Because colistin susceptibility testing is usually performed on demand when it becomes a treatment option results are delayed for up to 24 h. To reduce the time to results and provide simpler testing, several rapid tests have been developed [5,6,7]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Clinical Microbiology & Infectious Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
